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A 59-year-old woman with a history of lung sarcoidosis developed general edema and exertional dyspnea. An electrocardiogram
showed ﬁrst-degree atrioventricular block with complete right bundle branch block. Chest X-ray showed cardiomegaly.
Echocardiography showed diﬀuse and severe hypokinesis of the left ventricle (LV) and biventricular enlargement with severe
tricuspid regurgitation. Myocardial scintigraphy disclosed a perfusion defect at the ventricular septum and hypoperfusion at
the posterior wall and the apex. On cardiac catheterization, pulmonary capillary wedge pressure, right ventricular, and right
atrial pressures were elevated. Coronary angiograms were normal. Myocardial biopsy of the right ventricle histologically revealed
epithelioid cell granuloma with inﬁltration of ﬁbrous cells. The patient’s symptom and LV function were improved with
conventional medical therapy for heart failure. This is a rare case of cardiac sarcoidosis resulting in biventricular failure.
Copyright © 2009 Takefumi Ozaki et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Sarcoidosis is a granulomatous disease of unknown etiology
thatprimarilyaﬀects the lung and infrequently myocardium.
Myocardial sarcoidosis is known to cause cardiac arrhyth-
mias, electrical conduction disturbance, and rarely conges-
tive heart failure [1]. In cardiac sarcoidosis, left ventricle
(LV) is more frequently aﬀected than the right ventricle (RV)
and biventricular failure is rare. We report a case of cardiac
sarcoidosis complicated by severe biventricular failure. The
possibility of RV involvement by cardiac sarcoidosis was also
discussed.
2. Case Presentation
A59-year-oldwomanwasadmittedtothehospitalinJanuary
2001 due to exertional dyspnea and general edema with a
functional class III of New York Heart Association (NYHA),
which started from October 2000. She had suﬀered lung
sarcoidosis in 1987, when bilateral hilar lymphadenopathy
was noted on chest X-ray. She received no medication due
to absence of symptoms and organ dysfunctions.
On physical examination, blood pressure was 142/
90mmHg and pulse was regular with 120bpm. Pretibial
and facial edema was noted without swelling of super-
ﬁcial lymph nodes. Heart and respiratory sounds were
normal. Chest X-ray showed cardiomegaly with a car-
diothoracic ratio of 0.67 but normal lung ﬁeld. Com-
puted tomography of the chest and ultrasound of the
abdomen disclosed enlarged lymph nodes at the medi-
astinum and the hepatic hilus, respectively. An electrocar-
diogram (ECG) showed sinus tachycardia and ﬁrst-degree
atrioventricular block with complete right-bundle-branch-
block. A Holter ECG monitoring during 24hours showed
1275 beats of ventricular extrasystole with Lown grade
4B and 21 beats of supraventricular extrasystole. Two-
dimensional echocardiography showed enlarged biventri-
cles; left ventricular (LV) and right ventricular (RV) end-
diastolic dimension were 58mm and 45mm, respectively
(Figure 1). Diﬀuse and severe hypokinesis of the LV with
ejection fraction (EF) of 25% and fractional shortening
(FS) of 12% was shown without thinning of the LV wall.
Color Doppler echocardiography showed severe tricuspid
regurgitation.2 Case Reports in Medicine
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Figure 1: Echocardiography shows biventricular enlargement and
diﬀuse hypokinesis of the left ventricle without wall thinning.
Onlaboratorydata,completebloodcountandC-reactive
protein level were normal. Liver, renal, and thyroid functions
were also normal. Serum concentrations of lysozyme and
brain natriuretic peptide were increased to 12.9µg/mL
and 500.9pg/mL, respectively, while the concentration of
angiotension-converting enzyme was normal. Right heart
catheterization revealed elevations of pulmonary capil-
lary wedge pressure (mean 30mmHg), pulmonary artery
pressure (systolic 37mmHg, diastolic 30 mmHg, mean
33mmHg), RV ventricular pressure (systolic 36mmHg,
diastolic 20mmHg, end-diastolic 22mmHg), and right
atrial pressure (mean 23mmHg). Coronary angiograms
were normal but left ventriculography showed a diﬀuse
reduction in LV motion, especially in the anteroseptal and
apical wall motion. A His-bundle electrocardiogram showed
prolonged AH (164msec) and HV (60msec) intervals.
Myocardial scintigraphy using 99mTc-tetrofosmin
showed a perfusion defect at the ventricular septum and
hypoperfusion at the posterior wall and apex, whereas
67gallium scintigraphy showed no myocardial uptake.
Myocardial biopsy of the RV septum histologically showed
epithelioid cell granuloma with inﬁltration of ﬁbrous cells
into the area of lost myocytes (Figure 2), which conﬁrmed
myocardial sarcoidosis.
General edema disappeared with furosemide, spirono-
lactone and losartan, while exertional dyspnea and car-
diomegaly were sustained. Thus, beta-blocker therapy with
carvedilol was started with pimobendan and the dose was
step wisely increased to 10mg/day. When the patient was
discharged, exertional dyspnea disappeared and cardiac
function was improved to NYHA class II. One year later,
echocardiography showed an increment in LVEF to 34% and
ashorteningofLVend-diastolicdimensionto53mm,butno
change in RV dimension. Right-sided heart catheterization
showed pressure reductions in mean pulmonary capillary
wedge pressure to 15mmHg, RV end-diastolic pressure to
15mmHg, and mean right atrial pressure to 17mmHg.
Three years later, her cardiac function was further improved
to NYHA class I. Echocardiography showed further restored
LVEF to 54% and LV end-diastolic dimension to 45mm with
moderate tricuspid regurgitation. Throughout the clinical
course until then, corticosteroid therapy was not conducted.
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Figure 2: Myocardial scintigraphy with 99mTc-tetrofosmin shows
perfusion defect at the septal wall and hypoperfusion at the
posterior wall and apex.
3. Discussion
The prior history of lung sarcoidosis, the atrioventricular
block and the localized myocardial perfusion defect and
histologically identiﬁed epithelioid cell granuloma have con-
ﬁrmed a diagnosis of cardiac sarcoidosis in this case. Clinical
manifestations of cardiac sarcoidosis generally consist of
cardiac arrhythmia, electrical conduction disturbance, and
congestive heart failure, which occur in less than 5 percent of
the patients with sarcoidosis [2–4]. Congestive heart failure
mimicking dilated cardiomyopathy in cardiac sarcoidosisCase Reports in Medicine 3
Figure 3: Hematoxylin-Eosin staining of the myocardium from
ventricular septum discloses epithelioid cell granuloma.
has been reported as the consequence of diﬀuse myocar-
dial ﬁbrosis in cardiac sarcoidosis [5–7]. The present case
was characterized by severe biventricular heart failure that
subclinically progressed during 14 years after the diagnosis
of lung sarcoidosis. The ventricular septum showing the
myocardial perfusion defect coincided with the predisposing
site in cardiac sarcoidosis [7] and could account for the ECG
abnormality. As shown in our case, anteroseptal and apical
walls of the LV have been reported as preferentially aﬀected
cites in cardiac sarcoidosis [2].
We initially considered that RV enlargement and dys-
function were secondary to LV dysfunction and tricuspid
regurgitation. After the conventional medical therapy for
heart failure, LV dimension and function were signiﬁcantly
improved, while RV dimension was unchanged despite the
reduction in right-sided heart pressure. This suggested that
RV enlargement and dysfunction were in part due to RV
involvement by sarcoidosis.
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